Senior Manager, Business Development Global Evaluation

Novo Nordisk A/S; Cambridge (MA); Vor Ort; USD 150.000 - 200.000; Vollzeit

Benefits dieser Stelle

Company bonus

Long-term incentives

Company vehicle

Medical, dental, and vision coverage

401(k)

Zusammenfassung

Novo Nordisk Cambridge serves as the hub for Global Business Development, focusing on external partnerships, collaborations, and acquisitions across therapeutic areas. SE&I supports end-to-end BD activities, with responsibilities spanning sourcing, evaluation, due diligence, and alliance management.

The role demands independent project leadership within defined parameters, collaboration with global teams in Denmark and Cambridge, and engagement with biotech and pharma communities.

Qualifikationen

• Bachelor’s degree with 7+ years experience or Master’s with 5+ years or PhD with 3+ years in pharma/biotech or related field.
• Experience in R&D, business development or professional services within pharma/biotech.
• Ability to analyze data and present clear recommendations to senior stakeholders.

Aufgaben

• Identify novel pipeline assets and enabling technologies.
• Evaluate assets and conduct due diligence in collaboration with SE&I.
• Support BD processes from initial evaluation through due diligence.
• Prepare governance board presentations and manage due diligence projects.

Kenntnisse

Project management

Cross-functional collaboration

Strategic thinking

Communication skills

Networking

Ausbildung

Bachelor's degree

Master's degree

PhD/MD preferred

Jobbeschreibung

Facility: Business Development & Strategy

Location: Cambridge, MA, US

About the Department

The Novo Nordisk Cambridge location is the headquarters for Global Business Development across all of our therapeutic and technology areas. We contribute to innovation in one of the world's largest life sciences ecosystems by participating in events and discussions with renowned and upcoming scientists looking for the next scientific breakthrough to bring transformative treatments to patients. We work with start-ups, established companies, venture capitalists, teaching hospitals, and academic institutions to support the development of innovation for mutual benefit, and to help patients in all of our current therapy areas. Through a variety of partnership models, we accelerate ideas from the lab and clinic to advance and expand our product portfolio and to improve outcomes for the patients we serve

The Position

Global Business Development is responsible for Novo Nordisk’s corporate business development activities related to establishing external partnerships, collaborations and acquisitions, as well as integration and alliance management. The Group Vice President (GVP) area consists of units covering business development from end-to-end with Search, Evaluation & Intelligence, BD and M&A Transactions, Integration and Alliance Management. Search, Evaluation & Intelligence (SE&I) is part of GBD and acts as the primary entry point for external drug and technology opportunities relevant to Novo Nordisk. SE&I conducts proactive scouting campaigns to identify relevant opportunities by targeting start-ups, biotechnology companies and venture capital firms, by means of partnering events, scientific conferences and relevant industry events. The search for novel therapeutics focuses on our core areas: diabetes, obesity, CVD, Liver, blood & endocrine disorders and Consumer Rx. Working cross-functionally, SE&I supports the assessment of such external opportunities all the way to due diligence and contractual negotiation. The role is a driver for change in executing Novo Nordisk's strategy and business development activities on a global scale and has the following responsibilities: Identification of novel pipeline assets and enabling technologies. Strategic overview of internal, as well as BD, pipeline assets. Evaluation of novel pipeline assets and enabling technologies. Independence: Moderate. Works independently on specific projects, requiring guidance and input from manager/senior team members for broader strategy or significant issues. Decision-making: Moderate. Responsible for making decisions within defined parameters, leading projects, but often seeks approval from the manager for larger decisions.

Relationships

The position is part of the global SE&I evaluation team with members located predominantly in Denmark and Cambridge, MA, US. Reports to the Sr. Director, Global Evaluation. The role will interact cross-functionally with stakeholders from the entire value chain while working in close collaboration with Novo Nordisk’s Business Development teams located in Denmark and Cambridge. This position will also leverage their networks and actively engage with external stakeholders including biotech companies, venture capital firms and large-cap pharma communities. The role has no direct or indirect reports.

Essential Functions

• Contribute to and support identification of novel pipeline assets and enabling technologies
  • Contribute to scouting and report opportunities that may come across through professional networks or literature searches, databases or patent searches, conferences or other ways within relevant therapy areas, i.e. diabetes, obesity, CVD, Liver, rare blood/endocrine disorders and Consumer Rx
  • Support in-depth evaluation and due diligence process
  • Support the technical streams of the Business Development process from involvement in initial evaluation through due diligence processes
  • Assist in preparing presentations of selected opportunities to relevant governance boards; and building the value story for our opportunities, as well as due diligence project management, to enable senior management decision-making
  • Provide support to Business Development during negotiation of licenses and collaborations in alignment with SE&I
• Brand Novo Nordisk as the preferred partner within relevant therapy areas
  • Work cross-functionally with stakeholders from across the value chain
  • Participate in external scientific congresses or symposia and Novo Nordisk-sponsored events and meetings
  • Keep information and tracking of opportunities updated in Inova and in other formats if needed
• Landscaping
  • Contribute to and support the development and maintenance of detailed TA landscapes working across S&E functions
  • Provide external perspectives on competition and their TA strategies
• Strategic overview of internal, as well as BD pipeline assets
  • Through internal and external network, make sure what assets are needed for the TA as well as how they fit with the existing internal pipeline
• Contribute to the continuous improvement of core S&E processes including due diligence and landscaping (incl. improved collaboration and elimination of redundancy)
• Complete other tasks as assigned

Physical Requirements

10-20% overnight travel required; May require international travel.

Qualifications

• A bachelor’s degree from an accredited university and at least seven years of experience; a master’s degree and at least five years of experience; or a PhD and at least three years of experience. A master’s degree in business or life sciences is required. An MD or PhD is preferred
• 5+ years of experience in R&D, Business development, professional services withing the pharma/biotech industry or equivalent role
• Project management skills and experience
• Knowledge of or experience in clinical drug development in relevant therapeutic areas is an advantage
• Ability to analyse and digest ideas and data to make clear and qualified recommendations to senior stakeholders
• Experience working as part of cross-functional teams, ensuring clear communication and teamwork
• Strong communication skills, both in written and presentation form
• Outgoing with strong networking, collaboration and stakeholder management skills
• Curious, self-driven, solution- and goal-oriented individual who functions well in a dynamic environment
• Strategic business and financial acumen coupled with deep interest and curiosity about life sciences and medicine

The base compensation range for this position is $150,000 to $200,000. Base compensation is determined based on a number of factors. This position is also eligible for a company bonus based on individual and company performance. Novo Nordisk offers long-term incentive compensation and or company vehicles depending on the position's level or other company factors.

Employees are also eligible to participate in Company employee benefit programs including medical, dental and vision coverage; life insurance; disability insurance; 401(k) savings plan; flexible spending accounts; employee assistance program; tuition reimbursement program; and voluntary benefits such as group legal, critical illness, identity theft protection, pet insurance and auto/home insurance. The Company also offers time off pursuant to its sick time policy, flex-able vacation policy and parental leave policy.

We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.

At Novo Nordisk, we're not chasing quick fixes – we're creating lasting change for long-term health. For over 100 years, we've been driven by a single purpose: to defeat serious chronic diseases and help millions of people live healthier lives. This dedication fuels our constant curiosity and inspires us to push the boundaries of what's possible in healthcare. We embrace diverse perspectives, seek out bold ideas, and build partnerships rooted in shared purpose. Together, we're making healthcare more accessible, treating and defeating diseases, and pioneering solutions that create change spanning generations. When you join us, you become part of something bigger – a legacy of impact that reaches far beyond today.

Novo Nordisk is an equal opportunity employer. Qualified applicants will receive consideration for employment without regard to race, ethnicity, color, religion, sex, gender identity, sexual orientation, national origin, disability, protected veteran status or any other characteristic protected by local, state or federal laws, rules or regulations.